BioGaia AB (BGLAF)
11.55
0.00 (0.00%)
USD |
OTCM |
Oct 13, 16:00
BioGaia Gross Profit Margin (Quarterly) : 72.79% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.79% |
| March 31, 2026 | 71.61% |
| December 31, 2025 | 73.50% |
| September 30, 2025 | 74.24% |
| June 30, 2025 | 72.62% |
| March 31, 2025 | 73.27% |
| December 31, 2024 | 70.87% |
| September 30, 2024 | 73.14% |
| June 30, 2024 | 73.95% |
| March 31, 2024 | 71.89% |
| December 31, 2023 | 75.69% |
| September 30, 2023 | 74.24% |
| June 30, 2023 | 71.84% |
| March 31, 2023 | 71.76% |
| December 31, 2022 | 75.83% |
| September 30, 2022 | 72.08% |
| June 30, 2022 | 71.49% |
| March 31, 2022 | 71.24% |
| December 31, 2021 | 77.14% |
| September 30, 2021 | 73.55% |
| June 30, 2021 | 74.26% |
| March 31, 2021 | 71.89% |
| December 31, 2020 | 74.60% |
| September 30, 2020 | 67.83% |
| June 30, 2020 | 75.38% |
| Date | Value |
|---|---|
| March 31, 2020 | 72.76% |
| December 31, 2019 | 74.26% |
| September 30, 2019 | 72.97% |
| June 30, 2019 | 73.51% |
| March 31, 2019 | 72.65% |
| December 31, 2018 | 75.16% |
| September 30, 2018 | 74.75% |
| June 30, 2018 | 75.66% |
| March 31, 2018 | 73.90% |
| December 31, 2017 | 77.06% |
| September 30, 2017 | 73.69% |
| June 30, 2017 | 75.40% |
| March 31, 2017 | 74.93% |
| December 31, 2016 | 74.99% |
| September 30, 2016 | 72.42% |
| June 30, 2016 | 71.82% |
| March 31, 2016 | 70.80% |
| December 31, 2015 | 70.28% |
| September 30, 2015 | 67.77% |
| June 30, 2015 | 69.81% |
| March 31, 2015 | 70.46% |
| December 31, 2014 | 62.78% |
| September 30, 2014 | 65.43% |
| June 30, 2014 | 70.68% |
| March 31, 2014 | 83.13% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Hansa Biopharma AB | 53.57% |
| BioArctic AB | 91.24% |
| Swedish Orphan Biovitrum AB | 61.17% |
| Diamyd Medical AB | -27.69K% |
| BONESUPPORT HOLDING AB | 90.81% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 28.37% |
| Return on Assets | 23.27% |
| Return on Invested Capital | 28.34% |
| Profit Margin (Quarterly) | 23.40% |
| Operating Margin (Quarterly) | 28.39% |
| Return on Net Operating Assets | 83.17% |